Astera Labs, Inc. Common Stock

The stock remains in a powerful long-term uptrend, trading well above its 200-day average and far above its 52-week low of $88.73. After a sharp run toward the upper end of its range, the setup still favors momentum, though the distance from the 200-day line leaves room for consolidation.

Street sentiment stays constructive, with 13 Buy and 5 Hold ratings and no Sell ratings. The consensus target sits at $277.73, below the current share price, while recent calls mostly raised targets into the $400-$460 range and several firms kept neutral-to-positive stances.

The earnings profile is strong, with 7 straight EPS beats and a 13.0% beat on the last reported quarter. Next quarter is expected to show $0.42 EPS, and shareholders should watch whether revenue growth and margin expansion keep outrunning the already elevated bar.

Recent insider activity is clearly negative, led by 15 open-market sales from director Manuel Alba on July 1. With no insider buys in the period, the pattern points to distribution rather than accumulation, even if some sales may reflect personal portfolio management.

Profitability is already solid, with a 76.0% gross margin, 20.05% operating margin, and 26.72% net margin. Growth is still the main story, with revenue up 93.4% year over year and EPS growth at 144.4%, supported by $1.19 billion in cash and net cash of $1.15 billion.

Astera Labs stands out on growth and margin quality versus most semiconductor peers, especially in cloud and AI connectivity. The valuation remains demanding at 180.42x earnings, so the setup favors investors who want premium execution rather than a cheap multiple.